Persistent CD8+ T cell-driven immune dysregulation despite normalized CD4+ T cell recovery in ART-treated people living with HIV

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Despite successful antiretroviral therapy (ART) that restores CD4⁺ T cell counts and reduces HIV viral loads to undetectable levels, a substantial proportion of people living with HIV (PLWH) exhibit persistent CD4/CD8 ratio inversion. This abnormal ratio is primarily driven by sustained CD8⁺ T cell expansion and reflects a state of chronic immune dysregulation and incomplete immune recovery. However, cellular and molecular mechanisms underlying this discordant immune state remain poorly understood. Methods We analyzed longitudinal data of 5,416 ART-treated PLWH from Shenzhen Third People’s Hospital, identifying distinct CD8⁺ T cell trajectory groups using group-based trajectory modeling. We compared those with chronic stable activation (CSA group) versus those with immune modulation recovery (IMR group) using CyTOF-based immunophenotyping, bulk RNA sequencing, and plasma biomarker profiling. Results Both IMR and CSA groups achieved CD4⁺ T cell recovery, but CSA group exhibited persistently elevated CD8⁺ T cells and inverted CD4/CD8 ratios. The CSA group displayed a marked expansion of senescent and activated CD8⁺ T cell subsets and diminished regulatory T cells, characterized by decreased expression of CD196, CD95, and CD27. Bulk RNA sequencing revealed upregulation of interferon-stimulated genes, chemokine signaling pathways and pro-inflammatory transcriptional programs. Consistently, systemic levels of key inflammatory mediators, including IP-10, MCP-1, and soluble CD163, were significantly elevated in the CSA group. Conclusion Persistent CD8⁺ T cell activation reflects a distinct immunological state marked by CD4/CD8 ratio inversion, cell senescence, exhaustion, and systemic inflammation. This immune profile may help identify individuals at increased risk of non-AIDS complications and supports the rationale for targeting CD8⁺ T cell-driven immune dysregulation to improve long-term immune restoration.

Article activity feed